As of 06 Nov 2026 13:32 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/028 (22 Jun 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Disopyramide (Rythmodan®) 100mg capsulesaffected product · inferred from phrasing | Out of stock, as stated | early April 2027precision: early in the month · window end 10 Apr 2027, derived from “early April 2027” | notice of 22 Jun 2026 |
| Disopyramide (Rythmodan Retard®) 250mg modified release (MR) tabletsaffected product · inferred from phrasing | Out of stock, as stated⚠ the source line states more than one status — first stated shown | late July 2026precision: late in the month · window end 31 Jul 2026, derived from “late July 2026” | notice of 22 Jun 2026 |
| Parallel imports of disopyramide 250mg MR tablets and disopyramide 100mg capsulesparallel import named by the source · inferred from phrasing | Limited supply, as stated⚠ the source line states more than one status — first stated shown | — not stated for this line | notice of 22 Jun 2026 |
| Unlicensed specials of disopyramide 25mg/5ml and 50mg/5ml oral suspensionunlicensed import named by the source · inferred from phrasing | Stated as available | — not stated for this line | notice of 22 Jun 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Unlicensed specials of disopyramide 25mg/5ml and 50mg/5ml oral suspension — unlicensed import named by the source (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Disopyramide
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 5 times on record since 2022 — a recurring shortage spanning 4.2 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 22 Jun 2026 | Medicine Supply Notification: Disopyramide (Rythmodan® ) 100mg capsules and disopyramide (Rythmodan Retard® ) 250mg modified-release tablets | Supply notification | Tier 2 | MSN/2026/028 |
| 05 Jun 2024 | Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated | Supply notification | Tier 2 | MSN/2024/075 |
| 27 Sep 2023 | Medicine Supply Notification: Disopyramide (Rythmodan®)100mg capsules | Supply notification | Tier 2 | MSN/2023/091 |
| 11 Aug 2022 | Medicine Supply Notification: Disopyramide 150mg capsules | Supply notification | Tier 2 | MSN/2022/068 |
| 23 Mar 2022 | Medicine Supply Notification: Disopyramide 100mg and 150mg capsules | Supply notification | Tier 2 | MSN/2022/030 |
Also recorded under
Bracketed names seen in this medicine's notice titles: rythmodan, rythmodan retard. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)20 Disopyramide (Rythmodan®) 100mg capsules and disopyramide (Rythmodan · issued 25 Jun 2026 · valid until early April 2027 for Disopyramide (Rythmodan®) 100mg and, as stated · matched by name PDF ↗
- MSAN(2024)41 Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and · issued 05 Jul 2024 · valid until mid-January 2025, as stated · matched by name PDF ↗
- MSAN(2024)40 Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and · issued 28 Jun 2024 · valid until mid-January 2025, as stated · matched by name PDF ↗
- MSAN(2023)30 Disopyramide (Rythmodan®)100mg capsules · issued 04 Oct 2023 · valid until late October 2023, as stated · matched by name PDF ↗
- MSAN(2020)34 Disopyramide 150mg capsules · issued 01 May 2020 · valid until Early May 2020, as stated · matched by name PDF ↗
- MSAN(2020)24 DISOPYRAMIDE 150mg TABLETS · issued 16 Apr 2020 · valid until Late April 2020, as stated · matched by name PDF ↗
- MSAN(2019)17 DISOPYRAMIDE 150mg TABLETS · issued 15 Nov 2019 · valid until 13 December 2019, as stated · matched by name PDF ↗